Taken together, these results suggest that Xn and Xc regulate glucose homeostasis through LKB1-dependent AMPK activation and that the compounds are potential candidate drugs for the treatment of type 2 diabetes mellitus. The gene discussed is PRKAA2; the disease is type 2 diabetes mellitus.